Literature DB >> 16155003

The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells.

Grant R Campbell1, Jennifer D Watkins, Didier Esquieu, Eddy Pasquier, Erwann P Loret, Stephen A Spector.   

Abstract

HIV infection and the progression to AIDS are characterized by the depletion of CD4(+) T cells through apoptosis of the uninfected bystander cells and the direct killing of HIV-infected cells. This is mediated in part by the human immunodeficiency virus, type 1 Tat protein, which is secreted by virally infected cells and taken up by uninfected cells and CD178 gene expression, which is critically involved in T cell apoptosis. The differing ability of HIV strains to induce death of infected and uninfected cells may play a role in the clinical and biological differences displayed by HIV strains. We chemically synthesized the 86-residue truncated short variant of Tat and its full-length form. We show that the trans-activation ability of Tat at the long terminal repeat does not correlate with T cell apoptosis but that the ability of Tat to up-regulate CD178 mRNA expression and induce apoptosis in T cells is critically dependent on the C terminus of Tat. Moreover, the greater 86-residue Tat-induced apoptosis is via the extrinsic pathway of CD95-CD178.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16155003     DOI: 10.1074/jbc.M506630200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins.

Authors:  Grant R Campbell; Jennifer D Watkins; Erwann P Loret; Stephen A Spector
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-07       Impact factor: 2.205

Review 2.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

3.  A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade.

Authors:  Sonia Mediouni; Jennifer D Watkins; Michel Pierres; Angélique Bole; Erwann P Loret; Gilbert Baillat
Journal:  J Biol Chem       Date:  2012-02-23       Impact factor: 5.157

4.  Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins.

Authors:  Itzik Cooper; Keren Sasson; Vivian I Teichberg; Michal Schnaider-Beeri; Mati Fridkin; Yoram Shechter
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

5.  Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.

Authors:  Xuechao Zhao; Lingyu Qian; Deyu Zhou; Di Qi; Chang Liu; Xiaohong Kong
Journal:  Virol Sin       Date:  2016-03-21       Impact factor: 4.327

6.  Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes.

Authors:  Grant R Campbell; Jennifer D Watkins; Kumud K Singh; Erwann P Loret; Stephen A Spector
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.

Authors:  Justine K Wong; Grant R Campbell; Stephen A Spector
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

8.  CD4+ T cells in HIV infection show increased levels of expression of a receptor for vasoactive intestinal peptide, VPAC2.

Authors:  Hayley Ipp; Bongani B Nkambule; Timothy D Reid; Dalene de Swardt; Linda-Gail Bekker; Richard H Glashoff
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

9.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

10.  Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association.

Authors:  Altaira D Dearborn; Elif Eren; Norman R Watts; Ira W Palmer; Joshua D Kaufman; Alasdair C Steven; Paul T Wingfield
Journal:  Structure       Date:  2018-07-12       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.